Nanoparticles Engineered With Rituximab and Loaded With Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic Xenografts
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-13-0015
Full Text
Open PDFAbstract
Available in full text
Date
May 29, 2013
Authors
Publisher
American Association for Cancer Research (AACR)